Circulating tumor cells (CTCs) are accessible by liquid biopsies via an easy blood draw.
They represent not only the primary tumor site, but also potential metastatic lesions, and …

Liquid biopsy has seen tremendous progress over the past decade as it represents a
potential innovative solution to several limitations of current cancer management. By …

Background PD‐1 inhibitors are routinely used for the treatment of advanced melanoma.
This study sought to determine whether PD‐L1 expression on circulating tumor cells (CTCs) …

Background The validity of circulating tumour DNA (ctDNA) as an indicator of disease
progression compared to medical imaging in patients with metastatic melanoma requires …

Abstract Background Circulating tumour cells (CTCs) can be assessed through a minimally
invasive blood sample with potential utility as a predictive, prognostic and …

Circulating tumour cells (CTCs) are heterogenous and contain genetic information from the
tumour of origin. They bear specific intra-and extra-cellular protein markers aiding in their …

Human malignant melanoma shows a high rate of mortality after metastasization, and its
incidence is continuously rising worldwide. Several studies have suggested that …

The combination of liquid biomarkers from a single blood tube can provide more
comprehensive information on tumor development and progression in cancer patients …

Background: Circulating tumor cells (CTCs) have recently emerged as a new dynamic
soluble marker for several malignancies including cutaneous melanoma (CM) and are …

The analysis of hierarchical interactions has long been a challenging problem due to the
large number of candidate main effects and interaction effects, and the need for …